CEBPD
CCAAT/enhancer-binding protein delta
Also known as: C/EBP-delta, CEBPD_HUMAN, CELF, CRP3, NF-IL6-beta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49716
- Gene
- CEBPD
- Ensembl
- ENSG00000221869
- Chromosome
- 8
- Canonical length
- 269 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses, and may be involved in the regulation of genes associated with activation and/or differentiation of macrophages. The cytogenetic location of this locus has been reported as both 8p11 and 8q11. [provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
269 residues, UniProt reviewed canonical sequence.
>P49716|CEBPD
1 MSAALFSLDG PARGAPWPAE PAPFYEPGRA GKPGRGAEPG ALGEPGAAAP AMYDDESAID
61 FSAYIDSMAA VPTLELCHDE LFADLFNSNH KAGGAGPLEL LPGGPARPLG PGPAAPRLLK
121 REPDWGDGDA PGSLLPAQVA ACAQTVVSLA AAGQPTPPTS PEPPRSSPRQ TPAPGPAREK
181 SAGKRGPDRG SPEYRQRRER NNIAVRKSRD KAKRRNQEMQ QKLVELSAEN EKLHQRVEQL
241 TRDLAGLRQF FKQLPSPPFL PAAGTADCRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CEBPD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 475 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 475 nTPM
- ovary: 468 nTPM
- adipose tissue: 441 nTPM
- liver: 360 nTPM
- breast: 305 nTPM
- urinary bladder: 305 nTPM
Single-cell type
- epididymal basal cells: 1,717 nCPM
- neutrophils: 1,640 nCPM
- fallopian secretory cells: 1,553 nCPM
- smooth muscle cells: 1,325 nCPM
- pericytes: 1,320 nCPM
- alveolar cells type 2: 1,158 nCPM
Immune cell
- neutrophil: 55 nTPM
- classical monocyte: 20 nTPM
- eosinophil: 11 nTPM
- intermediate monocyte: 8.4 nTPM
- myeloid DC: 7.4 nTPM
- MAIT T-cell: 6.2 nTPM
Brain region
- medulla oblongata: 157 nTPM
- hypothalamus: 121 nTPM
- pons: 91 nTPM
- midbrain: 90 nTPM
- thalamus: 86 nTPM
- spinal cord: 85 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.61
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fat cell differentiation
- hematopoietic progenitor cell differentiation
- inner ear development
- integrated stress response signaling
- negative regulation of DNA-templated transcription
- positive regulation of osteoblast differentiation
- regulation of cell differentiation
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CEBPD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CEBPD as an antibody target. Whether an autoantibody or antibody against CEBPD could matter depends on whether native CEBPD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CEBPD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CEBPD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...